View on Pubmed.gov 23610422 | View on doi.org 10.1073/pnas.12...
Nontoxic radioactive Listeria(at) is a highly effective therapy against metastatic pancreatic cancer.
- Department of Microbiology and Immunology and Department of Radiology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Abstract
No significant improvement in therapy of pancreatic cancer has been reported over the last 25 y, underscoring the urgent need for new alternative therapies. Here, we coupled a radioisotope, (188)Rhenium, to an attenuated (at) live Listeria monocytogenes (Listeria(at)) using Listeria-binding antibodies, thus creating a unique radioactive Listeria(at) (RL). We then demonstrated in a highly metastatic pancreatic mouse tumor model (Panc-02) that RL delivered radioactivity to the metastases and less abundantly to primary tumors in vivo, without harming normal cells. This result was possible because Listeria(at) was efficiently cleared by the immune system in normal tissues but not in the heavily immune-suppressed microenvironment of metastases and primary tumor. Multiple treatments with low doses of the RL resulted in a dramatic decrease in the number of metastases (~90%) compared with control groups in the Panc-02 model. This is the first report of using live attenuated bacteria delivering a highly radioactive payload to the metastases, resulting in killing tumor cells in vivo without harming normal cells. The nontoxic RL treatment is attractive for clinical development as a therapy to prevent pancreatic cancer recurrence and metastases.
References
Br J Cancer. 2008 Sep 2;99(5):741-9
Cancer Res. 1984 Feb;44(2):717-26
J Immunol. 2001 Dec 1;167(11):6471-9
Nat Med. 2005 Aug;11(8):853-60
Cited by 163 citations (total)
Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review
Potent and tumor specific: arming bacteria with therapeutic proteins.
Electronic publication date July 21, 2015
Nele Van Dessel [...] Neil S Forbes et al.
Bacteria are perfect vessels for targeted cancer therapy. Conventional chemotherapy is limited by passive diffusion, and systemic administration causes severe...
Journal Article Review
Targeted radionuclide therapies for pancreatic cancer.
Electronic publication date May 14, 2016
M Shah [...] E Dadachova et al.
Pancreatic malignancies, the fourth leading cause of cancer deaths, have an aggressive behavior with poor prognosis, resulting in a 5-year...
Conflict of interest statement
MeSH
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
Substances
- •